Overview
Status
Active
Registry date
2010-12-24
Share capital
6,000.00 PLN
Registered address
Łąkowa 7 A, 90-562 Łódź, Poland
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 63 days late).
- 202514/07/2026
- 202408/07/2025
- 202314/07/2024
- 202210/07/2023
- 202116/09/2022
- 202016/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Mileniusz Cezary Piekarek – Management Board Member
Michał Łukasz Piekarek – Management Board Member
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michał Łukasz Piekarekage 34 | 60 | $810.37 | 50% |
Mileniusz Cezary Piekarekage 59 | 60 | $810.37 | 50% |
Michał Łukasz Piekarek and Mileniusz Cezary Piekarek hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DOZ Directsp. k. | $767,165,903.98 | doz.pl | ||
| Hammermed Medical PolskaS.K.A. | $93,061,305.58 | hammer.pl | ||
| Citonet-Łódźsp. z o.o. | $9,932,231.75 | citonet.pl | ||
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| CanpolandS.A. | $328,824.15 | canpoland.com | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Polska Grupa FarmaceutycznaS.A. | – | pgf.com.pl | ||
| BEH Polsp. z o.o. | – | beh-pol.com |
Change history
| Date | Event | |
|---|---|---|
| 2016-07-06 | PKD change (Removed: 43 codes; Added: 2 codes) | |
| 2012-06-11 | Address change (Nastrojowa 58/17, 91-496, Łódź → Łąkowa 7 A, 90-562, Łódź) | |
| 2010-12-24 | Entered in the register |
FAQ
The main business activity of BMK Polska focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on December 24, 2010.
The headquarters is located at: Łąkowa 7 A, 90-562 Łódź.
The share capital of the company is PLN 6,000 (approx. $1,621).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $1,077.
Yes, the company recorded a net profit of $86 in 2024.
The largest operating cost category falls under external services. This category amounted to $991 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-17